Abbott Laboratories (ABT)
115.29
+0.53
(+0.46%)
USD |
NYSE |
Dec 26, 15:37
Abbott Laboratories Research and Development Expense (Quarterly): 713.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| Haemonetics Corp | 16.53M |
| Globus Medical Inc | 35.38M |
| Becton Dickinson & Co | 302.00M |
| Masimo Corp | 48.30M |